Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1519670
Disease: Tumor Angiogenesis
Tumor Angiogenesis
0.100 Biomarker phenotype BEFREE Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein. 23707765 2013
CUI: C1519670
Disease: Tumor Angiogenesis
Tumor Angiogenesis
0.100 AlteredExpression phenotype BEFREE When used alone or in combination with LXY-LS-DOX, M-RAPA could greatly inhibit the expression of HIF-1α protein, which is always highly expressed in malignant cancers and involved in tumor angiogenesis, proliferation, therapeutic resistance and poor prognosis. 24726747 2014
CUI: C1519670
Disease: Tumor Angiogenesis
Tumor Angiogenesis
0.100 Biomarker phenotype BEFREE We put a special focus on the transcription factor HIF-1α, a master regulator of tumor angiogenesis.The interaction of CDK5 with HIF-1α was tested by Western blot, PCR, reporter gene assay, immunohistochemistry, kinase assay, co-immunoprecipitation, mass spectrometry, and mutation studies. 27027353 2016
CUI: C1519670
Disease: Tumor Angiogenesis
Tumor Angiogenesis
0.100 Biomarker phenotype BEFREE We provide a possible mechanism in which peritoneal dissemination of gastric cancer develops via a vascular network whereby HIF-1α activates tumor angiogenesis. 23970191 2013
CUI: C1519670
Disease: Tumor Angiogenesis
Tumor Angiogenesis
0.100 AlteredExpression phenotype BEFREE We propose that the mechanism underlying the inhibitory effects of bortezomib on tumor angiogenesis and hypoxic adaptation involves the repression of HIF-1alpha transcriptional activity by reinforcing the FIH-mediated inhibition of p300 recruitment. 18174379 2008
CUI: C1519670
Disease: Tumor Angiogenesis
Tumor Angiogenesis
0.100 AlteredExpression phenotype BEFREE We examined the effect of nelfinavir, an HIV protease inhibitor that inhibits Akt signaling, on VEGF and HIF-1alpha expression and on angiogenesis, tumor oxygenation, and radiosensitization. 16982770 2006
CUI: C1519670
Disease: Tumor Angiogenesis
Tumor Angiogenesis
0.100 Biomarker phenotype BEFREE Vascular endothelial growth factor A (VEGFA), a critical mediator of tumor angiogenesis, is a well-characterized target of hypoxia-inducible factor 1 (HIF-1). 20194889 2010
CUI: C1519670
Disease: Tumor Angiogenesis
Tumor Angiogenesis
0.100 Biomarker phenotype BEFREE Vascular endothelial growth factor (VEGF), a crucial factor in tumor angiogenesis, has been reported to be transcriptionally regulated by hypoxia-inducible factor-1 (HIF-1). 30906512 2019
CUI: C1519670
Disease: Tumor Angiogenesis
Tumor Angiogenesis
0.100 AlteredExpression phenotype BEFREE Using ovarian and endometrial cancer cell lines, we observed that TM downregulates HIF-1α protein levels and HIF-transcriptional targets involved in tumor angiogenesis and glycolysis, but did not affect HIF-1α protein synthesis. 26469226 2015
CUI: C1519670
Disease: Tumor Angiogenesis
Tumor Angiogenesis
0.100 Biomarker phenotype BEFREE Under hypoxic conditions, mARD1(225) autoacetylation inhibited tumor angiogenesis by decreasing the stability of hypoxia-inducible factor-1α (HIF-1α). 25338643 2015
CUI: C1519670
Disease: Tumor Angiogenesis
Tumor Angiogenesis
0.100 AlteredExpression phenotype BEFREE Tumor necrosis factor receptor-associated factor 6 (TRAF6) promotes tumor angiogenesis via upregulating the expression of hypoxia-inducible factor 1α (HIF-1α) and vascular endothelial growth factor (VEGF). 30103950 2018
CUI: C1519670
Disease: Tumor Angiogenesis
Tumor Angiogenesis
0.100 Biomarker phenotype BEFREE To the best of our knowledge, results of the present study provide the first evidence that miR-181b was upregulated by hypoxia in retinoblastoma in an HIF-1α-independent manner. miR-181b increased tumor angiogenesis of retinoblastoma cells. 25872572 2015
CUI: C1519670
Disease: Tumor Angiogenesis
Tumor Angiogenesis
0.100 AlteredExpression phenotype BEFREE To investigate the implication of the hypoxia inducible factor HIF-1alpha mRNA in gastric carcinoma and its relation to the expression of vascular endothelial growth factor (VEGF) protein, tumor angiogenesis invasion/metastasis and the patient's survival. 17461470 2007
CUI: C1519670
Disease: Tumor Angiogenesis
Tumor Angiogenesis
0.100 Biomarker phenotype BEFREE Thus, LSD1 is a key regulator of HIF1α/VEGF-mediated tumor angiogenesis by antagonizing the crosstalk between PTMs involving HIF1α protein degradation. 28534506 2017
CUI: C1519670
Disease: Tumor Angiogenesis
Tumor Angiogenesis
0.100 Biomarker phenotype BEFREE This study aimed at determining the expression levels of HIF-1alpha and vascular endothelial growth factor (VEGF) in SW480 cells and in colorectal adenocarcinoma tissue and ascertaining whether HIF-1alpha and VEGF play important roles in tumor angiogenesis. 15498380 2004
CUI: C1519670
Disease: Tumor Angiogenesis
Tumor Angiogenesis
0.100 AlteredExpression phenotype BEFREE These results showed that TSA had a potent anticancer activity on TSCC cells, suggesting that TSA could be a promising drug targeting tumor angiogenesis via inhibition of HIF-1α and VEGF expression in the development of an effective chemopreventive and anticancer agent on human TSCCs. 22552321 2012
CUI: C1519670
Disease: Tumor Angiogenesis
Tumor Angiogenesis
0.100 AlteredExpression phenotype BEFREE These results indicated that in prostate cancers, HIF-1 might cooperate with the AR to activate the expression of several genes related to tumor angiogenesis, invasion, and progression. 17426252 2007
CUI: C1519670
Disease: Tumor Angiogenesis
Tumor Angiogenesis
0.100 Biomarker phenotype BEFREE These results demonstrate that BH4 domain of bcl-2 is required for the ability of this protein to increase tumor angiogenesis and progression and indicate that bcl-2 nuclear localization may be required for bcl-2-mediated induction of HIF-1/VEGF axis. 23836782 2013
CUI: C1519670
Disease: Tumor Angiogenesis
Tumor Angiogenesis
0.100 AlteredExpression phenotype BEFREE These findings reveal a novel role of apigenin in inhibiting HIF-1 and VEGF expression that is important for tumor angiogenesis and growth, identifying new signaling molecules that mediate this regulation. 15746177 2005
CUI: C1519670
Disease: Tumor Angiogenesis
Tumor Angiogenesis
0.100 AlteredExpression phenotype BEFREE These data provide a molecular basis for VEGF induction and tumor angiogenesis by heregulin-HER2 signaling and establish a novel mechanism for the regulation of HIF-1alpha expression. 11359907 2001
CUI: C1519670
Disease: Tumor Angiogenesis
Tumor Angiogenesis
0.100 AlteredExpression phenotype BEFREE These data indicate that activation of c-Kit by SCF leads to a predominantly HIF-1alpha-mediated enhancement of VEGF expression and that inhibition of c-Kit signaling with imatinib could result in inhibition of tumor angiogenesis. 16818499 2006
CUI: C1519670
Disease: Tumor Angiogenesis
Tumor Angiogenesis
0.100 Biomarker phenotype BEFREE Therefore, heparanase and HIF-1α facilitated tumor angiogenesis and promoted pulmonary metastasis of osteosarcoma. 20845995 2010
CUI: C1519670
Disease: Tumor Angiogenesis
Tumor Angiogenesis
0.100 AlteredExpression phenotype BEFREE There is strong scientific rationale for combination therapy: transarterial chemoembolization produces ischemia and stimulates hypoxia-inducible factor-1α, resulting in a local and systemic upregulation of vascular endothelial growth factor (VEGF), which can increase tumor angiogenesis. 23562168 2013
CUI: C1519670
Disease: Tumor Angiogenesis
Tumor Angiogenesis
0.100 AlteredExpression phenotype BEFREE The transcription factor hypoxia-inducible factor-1α (HIF-1α) plays an important role in tumor angiogenesis, growth, and metastasis and is recognized as an important potential therapeutic target for cancer. 30728113 2019
CUI: C1519670
Disease: Tumor Angiogenesis
Tumor Angiogenesis
0.100 AlteredExpression phenotype BEFREE The results suggest that Trx-1 increases HIF-1alpha protein levels in cancer cells and increases VEGF production and tumor angiogenesis. 12208766 2002